Sera Prognostics (SERA) Competitors $2.97 +0.27 (+10.00%) Closing price 04:00 PM EasternExtended Trading$2.96 -0.01 (-0.34%) As of 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SERA vs. EHAB, AIRS, TOI, VMD, XGN, DCGO, EUDA, CORBF, QIPT, and KDLYShould you be buying Sera Prognostics stock or one of its competitors? The main competitors of Sera Prognostics include Enhabit (EHAB), AirSculpt Technologies (AIRS), Oncology Institute (TOI), Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), EUDA Health (EUDA), Global Cord Blood (CORBF), Quipt Home Medical (QIPT), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry. Sera Prognostics vs. Its Competitors Enhabit AirSculpt Technologies Oncology Institute Viemed Healthcare Exagen DocGo EUDA Health Global Cord Blood Quipt Home Medical Kindly MD Enhabit (NYSE:EHAB) and Sera Prognostics (NASDAQ:SERA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation. Which has stronger earnings and valuation, EHAB or SERA? Sera Prognostics has lower revenue, but higher earnings than Enhabit. Sera Prognostics is trading at a lower price-to-earnings ratio than Enhabit, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnhabit$1.03B0.33-$156.20M-$2.77-2.47Sera Prognostics$80K1,398.50-$32.90M-$0.94-3.16 Do institutionals and insiders have more ownership in EHAB or SERA? 54.6% of Sera Prognostics shares are held by institutional investors. 3.4% of Enhabit shares are held by company insiders. Comparatively, 15.8% of Sera Prognostics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor EHAB or SERA? In the previous week, Enhabit and Enhabit both had 2 articles in the media. Enhabit's average media sentiment score of 0.92 beat Sera Prognostics' score of 0.30 indicating that Enhabit is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enhabit 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sera Prognostics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is EHAB or SERA more profitable? Enhabit has a net margin of -13.43% compared to Sera Prognostics' net margin of -28,685.22%. Enhabit's return on equity of 2.02% beat Sera Prognostics' return on equity.Company Net Margins Return on Equity Return on Assets Enhabit-13.43% 2.02% 0.94% Sera Prognostics -28,685.22%-51.35%-37.21% Do analysts rate EHAB or SERA? Enhabit presently has a consensus target price of $8.75, indicating a potential upside of 27.96%. Given Enhabit's stronger consensus rating and higher probable upside, equities analysts plainly believe Enhabit is more favorable than Sera Prognostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enhabit 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Sera Prognostics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk & volatility, EHAB or SERA? Enhabit has a beta of 1.72, suggesting that its share price is 72% more volatile than the S&P 500. Comparatively, Sera Prognostics has a beta of 0.99, suggesting that its share price is 1% less volatile than the S&P 500. SummaryEnhabit beats Sera Prognostics on 10 of the 15 factors compared between the two stocks. Get Sera Prognostics News Delivered to You Automatically Sign up to receive the latest news and ratings for SERA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SERA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SERA vs. The Competition Export to ExcelMetricSera PrognosticsMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$111.88M$7.17B$5.57B$9.32BDividend YieldN/A2.86%4.23%4.03%P/E Ratio-3.1634.5128.6419.75Price / Sales1,398.5036.76432.34182.50Price / CashN/A25.1136.0257.96Price / Book2.128.218.235.67Net Income-$32.90M$236.06M$3.24B$257.98M7 Day Performance11.65%-2.03%0.05%0.56%1 Month Performance66.85%0.97%5.65%8.88%1 Year Performance-61.33%18.84%26.57%14.24% Sera Prognostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SERASera Prognostics0.3976 of 5 stars$2.97+10.0%N/A-61.6%$111.88M$80K-3.16120EHABEnhabit3.2673 of 5 stars$7.05+0.1%$8.75+24.0%-23.7%$357.19M$1.03B-2.5510,700High Trading VolumeAIRSAirSculpt Technologies1.0392 of 5 stars$5.24+5.2%$3.75-28.4%+9.9%$308.01M$172.10M-17.47240High Trading VolumeTOIOncology Institute1.8609 of 5 stars$3.21+2.6%$7.00+118.1%+494.0%$286.44M$403.15M-4.59660Analyst ForecastGap UpHigh Trading VolumeVMDViemed Healthcare1.2262 of 5 stars$6.72-0.3%N/A-3.1%$265.57M$224.26M22.401,179XGNExagen3.3316 of 5 stars$7.07+1.1%$7.50+6.1%+242.4%$150.59M$56.72M-8.42220News CoveragePositive NewsHigh Trading VolumeDCGODocGo2.1835 of 5 stars$1.46-2.0%$3.56+143.8%-55.3%$148.90M$520.50M-73.004,407Positive NewsEUDAEUDA Health1.2549 of 5 stars$3.29-0.3%N/A-15.4%$122.24M$4.01M0.002Positive NewsCORBFGlobal Cord BloodN/A$0.75flatN/AN/A$91.16M$196.12M0.001,200Gap DownQIPTQuipt Home Medical2.9558 of 5 stars$1.90+1.6%$2.85+50.0%-35.3%$82.54M$240.85M-9.051,200KDLYKindly MDN/A$12.30-7.5%N/A+414.5%$74.07M$2.47M-15.97N/A Related Companies and Tools Related Companies EHAB Competitors AIRS Competitors TOI Competitors VMD Competitors XGN Competitors DCGO Competitors EUDA Competitors CORBF Competitors QIPT Competitors KDLY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SERA) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s Little-Known Succession PlanYou could miss out on millions buying a house - even if prices rise Joel Litman is a millionaire member of ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sera Prognostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sera Prognostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SERA Stock Alerts